Manuel Jurado

2.4k total citations
37 papers, 670 citations indexed

About

Manuel Jurado is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Manuel Jurado has authored 37 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 11 papers in Oncology and 9 papers in Genetics. Recurrent topics in Manuel Jurado's work include Hematopoietic Stem Cell Transplantation (7 papers), Acute Myeloid Leukemia Research (6 papers) and Multiple Myeloma Research and Treatments (6 papers). Manuel Jurado is often cited by papers focused on Hematopoietic Stem Cell Transplantation (7 papers), Acute Myeloid Leukemia Research (6 papers) and Multiple Myeloma Research and Treatments (6 papers). Manuel Jurado collaborates with scholars based in Spain, Italy and Germany. Manuel Jurado's co-authors include Juan Sáinz, Antonio Romero, Salvador Oyonarte, Rafael Ríos, Elisa López‐Fernández, Lourdes Vázquez, Kari Hemminki, Asta Försti, María Collado and Francisco Ruiz‐Cabello and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Annals of Internal Medicine.

In The Last Decade

Manuel Jurado

34 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuel Jurado Spain 15 253 227 210 153 131 37 670
Fabrice Larosa France 17 178 0.7× 301 1.3× 309 1.5× 112 0.7× 144 1.1× 36 780
Hilde Demuynck Belgium 11 217 0.9× 284 1.3× 266 1.3× 86 0.6× 153 1.2× 28 689
Mingzhe Han China 14 419 1.7× 179 0.8× 221 1.1× 189 1.2× 224 1.7× 102 884
Nobuyuki Takayama Japan 15 242 1.0× 84 0.4× 232 1.1× 135 0.9× 120 0.9× 55 753
Johannes Clausen Austria 16 349 1.4× 225 1.0× 287 1.4× 433 2.8× 287 2.2× 44 1.1k
Pietro Leoni Italy 17 290 1.1× 184 0.8× 231 1.1× 177 1.2× 345 2.6× 44 1.0k
Prashant Hiwarkar United Kingdom 12 288 1.1× 102 0.4× 245 1.2× 179 1.2× 189 1.4× 27 607
Kit-Fai Wong China 11 201 0.8× 241 1.1× 293 1.4× 446 2.9× 364 2.8× 17 1.0k
Yunfeng Li China 11 241 1.0× 62 0.3× 86 0.4× 172 1.1× 96 0.7× 32 609
Giuliana Muti Italy 15 107 0.4× 235 1.0× 263 1.3× 91 0.6× 335 2.6× 29 761

Countries citing papers authored by Manuel Jurado

Since Specialization
Citations

This map shows the geographic impact of Manuel Jurado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Jurado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Jurado more than expected).

Fields of papers citing papers by Manuel Jurado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Jurado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Jurado. The network helps show where Manuel Jurado may publish in the future.

Co-authorship network of co-authors of Manuel Jurado

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Jurado. A scholar is included among the top collaborators of Manuel Jurado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Jurado. Manuel Jurado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morata‐Tarifa, Cynthia, Natividad Cuende, Manuel Jurado, et al.. (2022). Mesenchymal Stromal Cells for Treating Steroid-Resistant Acute and Chronic Graft Versus Host Disease: A Multicenter Compassionate Use Experience. Stem Cells Translational Medicine. 11(4). 343–355. 16 indexed citations
2.
López‐Nevot, Miguel Ángel, Paloma García, Manuel Martínez‐Bueno, et al.. (2022). Autophagy in Hematological Malignancies. Cancers. 14(20). 5072–5072. 9 indexed citations
3.
Callejas-Rubio, José Luís, et al.. (2020). Hemophagocytic lymphohistiocytosis associated with Leishmania: A hidden passenger in endemic areas. Enfermedades Infecciosas y Microbiología Clínica. 39(4). 188–191. 7 indexed citations
4.
Sgherza, Nicola, Juan Sáinz, Federica Gemignani, et al.. (2020). Genetic polymorphisms associated with telomere length and risk of developing myeloproliferative neoplasms. Blood Cancer Journal. 10(8). 89–89. 17 indexed citations
5.
Kwon, Mi, Rebeca Bailén, Pascual Balsalobre, et al.. (2019). Allogeneic stem-cell transplantation in HIV-1-infected patients with high-risk hematological disorders. AIDS. 33(9). 1441–1447. 14 indexed citations
6.
Bernal, Mónica, Amanda Rocío González Ramírez, Pilar Jiménez, et al.. (2019). Tumor genetic alterations and features of the immune microenvironment drive myelodysplastic syndrome escape and progression. Cancer Immunology Immunotherapy. 68(12). 2015–2027. 36 indexed citations
7.
Salgado, María, Mi Kwon, Cristina Gálvez, et al.. (2018). Mechanisms That Contribute to a Profound Reduction of the HIV-1 Reservoir After Allogeneic Stem Cell Transplant. Annals of Internal Medicine. 169(10). 674–683. 34 indexed citations
10.
Jurado, Manuel, Elisa López‐Fernández, O. Espinosa, et al.. (2017). Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: A phase I/II study. Cytotherapy. 19(8). 927–936. 53 indexed citations
11.
Ríos, Rafael, María‐José Sánchez, José Manuel Puerta, et al.. (2015). Trends in survival of multiple myeloma: A thirty-year population-based study in a single institution. Cancer Epidemiology. 39(5). 693–699. 20 indexed citations
12.
Bueno, Clara, Eduardo Anguita, Damià Romero–Moya, et al.. (2014). Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease. Haematologica. 99(7). 1168–1175. 24 indexed citations
13.
Sáinz, Juan, Lourdes Vázquez, Rafael Ríos, et al.. (2012). Dectin-1 and DC-SIGN Polymorphisms Associated with Invasive Pulmonary Aspergillosis Infection. PLoS ONE. 7(2). e32273–e32273. 106 indexed citations
14.
Aparicio, Virginia A., Elena Nebot, Garyfallia Kapravelou, et al.. (2011). El entrenamiento de fuerza reduce la acidosis metabólica y la hipertrofia hepática y renal consecuentes del consumo de una dieta hiperproteica en ratas. Nutrición Hospitalaria. 26(6). 1478–1486. 5 indexed citations
15.
Navarro, Pilar, et al.. (2008). Información, ansiedad y depresión en pacientes sometidos a trasplante de progenitores hematopoyéticos (TPH) en un estudio de intervención psicológica. Complutensian Scientific Journals (Complutense University of Madrid). 4(1). 97–109. 2 indexed citations
16.
Romero, Antonio A., et al.. (2008). Information, anxiety and depression in patients submitted to bone marrow transplantation (BMT) in a study of psychological intervention. SHILAP Revista de lepidopterología. 2 indexed citations
17.
Sáinz, Juan, et al.. (2007). Interleukin-10 promoter polymorphism as risk factor to develop invasive pulmonary aspergillosis. Immunology Letters. 109(1). 76–82. 59 indexed citations
19.
Romero, Alfonso E., et al.. (2002). Expansion of cells with trisomy 12 associated with progressive lymphocytosis and a dramatic change in chimera status in a patient with chronic lymphocytic leukemia.. PubMed. 87(7). ECR25–ECR25. 2 indexed citations
20.
Jurado, Manuel, H. Joachim Deeg, Barry E. Storer, et al.. (2002). Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome after conditioning with busulfan and fractionated total body irradiation is associated with low relapse rate but considerable nonrelapse mortality. Biology of Blood and Marrow Transplantation. 8(3). 161–169. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026